Business Development

The technology platform Marinosolv® enables novel stable aqueous formulations of hardly soluble compounds such as but not limited to corticosteroids, allowing a faster onset of action and a better bioavailability. Please contact us for further information.

Are you interested in making your insoluble compound dissolved in an aqueous solution?
Do you want to learn more about the pipeline products of Marinomed and its partnering availability?
Do you want to discuss other potential collaborations?

Marinomed Biotech AG provides Solv4U technology partnerships to address the solubility and bioavailability issues and to support formulation development of hardly water-soluble Active Pharmaceutical Ingredients (APIs) in all stages of drug discovery based on its proprietary innovative Marinosolv® technology platform. For more information on Solv4U-Partnerships, please visit: www.solv4u.com.

Please contact our business development.

Contact

Dr. Renate Moser
Head of Business Development

Phone: +43 2262 90300
Email: bd@marinomed.com